In India two more ant covid vaccines have been given emergency approval. The Central Drugs Standard Control Organisation has given approval to Corbevax vaccine, Covovax vaccine and anti-viral drug Molnupiravir for restricted use in emergency situations. In a series of tweets, Union Health Minister Mansukh Mandaviya said, Corbevax vaccine is India's first indigenously developed RBD protein sub-unit vaccine against COVID-19, made by Hyderabad-based firm Biological-E. It is the third vaccine developed in India.
Congratulations India
— Dr Mansukh Mandaviya (@mansukhmandviya) December 28, 2021
Further strengthening the fight against COVID-19, CDSCO, @MoHFW_INDIA has given 3 approvals in a single day for:
- CORBEVAX vaccine
- COVOVAX vaccine
- Anti-viral drug Molnupiravir
For restricted use in emergency situation. (1/5)
The Nanoparticle Vaccine, Covovax, will be manufactured by Pune-based firm Serum Institute of India. Mandaviya said, Molnupiravir will now be manufactured in the country by 13 companies for restricted use under emergency situation for treatment of adult patients with COVID-19 and who have high risk of progression of the disease.
Newsinc24 Team





Related Items
Army officers survive chopper crash in Leh, their selfie goes viral
Anti-Doping Act set to be amended again
NCB makes first-ever seizure of ‘Jihadi Drug’ Captagon